Mary Matli

1.6k total citations · 1 hit paper
20 papers, 1.3k citations indexed

About

Mary Matli is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Mary Matli has authored 20 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Epidemiology. Recurrent topics in Mary Matli's work include Cancer, Hypoxia, and Metabolism (5 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Herpesvirus Infections and Treatments (4 papers). Mary Matli is often cited by papers focused on Cancer, Hypoxia, and Metabolism (5 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Herpesvirus Infections and Treatments (4 papers). Mary Matli collaborates with scholars based in United States, Switzerland and Mali. Mary Matli's co-authors include Robert S. Warren, Hui Yuan, Napoleone Ferrara, Nancy A. Gillett, David B. Donner, Hui Yuan, N. Ferrara, Avraham Lalazar, Scott L. Friedman and Victor Ankoma‐Sey and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Cell Biology.

In The Last Decade

Mary Matli

20 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis.

1995 575 citations Robert S. Warren, Hui Yuan et al. Journal of Clinical Investigation profile →

Peers

Mary Matli

ONCOL

PRM

HEPAT

M Furutani Japan

Jik Young Park South Korea

C Lu Japan

Lucia Fallavollita Canada

Carlo Gatti Italy

Heike Varnholt United States

Anna Sankila Finland

Shu Shimada Japan

Kyoko Iwao Japan

Pinzhu Huang China

M Furutani Japan

Mary Matli

593 ×0.7

354 ×0.8

ONCOL

378 ×0.9

115 ×0.7

PRM

236 ×1.5

HEPAT

Citations per year, relative to Mary Matli Mary Matli (= 1×) peers M Furutani

Countries citing papers authored by Mary Matli

Since Specialization

Citations

This map shows the geographic impact of Mary Matli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Matli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Matli more than expected).

Fields of papers citing papers by Mary Matli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Matli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Matli. The network helps show where Mary Matli may publish in the future.

Co-authorship network of co-authors of Mary Matli

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Matli. A scholar is included among the top collaborators of Mary Matli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Matli. Mary Matli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Toriguchi, Kan, et al.. (2022). STAT3 regulates inflammatory cytokine production downstream of TNFR1 by inducing expression of TNFAIP3/A20. Journal of Cellular and Molecular Medicine. 26(16). 4591–4601. 13 indexed citations

Bonnans, Caroline, Delphine Grün, Chih‐Yang Wang, et al.. (2019). RasGRP1 is a potential biomarker for stratifying anti-EGFR therapy response in colorectal cancer. JCI Insight. 4(15). 18 indexed citations

Depeille, Philippe, Linda M. Henricks, Robert A. H. van de Ven, et al.. (2015). RasGRP1 opposes proliferative EGFR–SOS1–Ras signals and restricts intestinal epithelial cell growth. Nature Cell Biology. 17(6). 804–815. 52 indexed citations

Ducker, Gregory S., Chloé E. Atreya, Jeff Simko, et al.. (2013). Incomplete inhibition of phosphorylation of 4E-BP1 as a mechanism of primary resistance to ATP-competitive mTOR inhibitors. Oncogene. 33(12). 1590–1600. 75 indexed citations

Atreya, Chloé E., Zaina Sangale, Mary Matli, et al.. (2013). PTEN expression is consistent in colorectal cancer primaries and metastases and associates with patient survival. Cancer Medicine. 2(4). 496–506. 40 indexed citations

Atreya, Chloé E., Zaina Sangale, Mary Matli, et al.. (2013). Abstract 1201: PTEN null expression is concordant in colorectal cancer primaries and metastases and associates with poor survival.. Cancer Research. 73(8_Supplement). 1201–1201. 1 indexed citations

Lacher, Markus D., Roxana Pincheira, Zhou Zhu, et al.. (2010). Rheb activates AMPK and reduces p27Kip1 levels in Tsc2-null cells via mTORC1-independent mechanisms: implications for cell proliferation and tumorigenesis. Oncogene. 29(50). 6543–6556. 35 indexed citations

Wang, Yucheng, Gioia Iezza, Xiaochen Yuan, et al.. (2008). Homeodomain transcription factor NKX2.2 functions in immature cells to control enteroendocrine differentiation and is expressed in gastrointestinal neuroendocrine tumors. Endocrine Related Cancer. 16(1). 267–279. 31 indexed citations

Arvold, Nils D., Neela Guha, Dongfang Wang, et al.. (2005). Hypoxia-induced radioresistance is independent of hypoxia-inducible factor-1A in vitro. International Journal of Radiation Oncology*Biology*Physics. 62(1). 207–212. 19 indexed citations

10.

Bhisitkul, Robert B., et al.. (2004). HIF–1–mediated induction of VEGF in RPE cells: upregulation by constitutively active HIF–1 and inhibition by RNA interference. Investigative Ophthalmology & Visual Science. 45(13). 452–452. 1 indexed citations

11.

Wang, Dongfang, et al.. (2002). Expression and endocytosis of VEGF and its receptors in human colonic vascular endothelial cells. American Journal of Physiology-Gastrointestinal and Liver Physiology. 282(6). G1088–G1096. 42 indexed citations

12.

Ankoma‐Sey, Victor, Mary Matli, Avraham Lalazar, et al.. (1998). Coordinated induction of VEGF receptors in mesenchymal cell types during rat hepatic wound healing. Oncogene. 17(1). 115–121. 95 indexed citations

13.

Warren, Robert S., Hui Yuan, Mary Matli, N. Ferrara, & David B. Donner. (1996). Induction of Vascular Endothelial Growth Factor by Insulin-like Growth Factor 1 in Colorectal Carcinoma. Journal of Biological Chemistry. 271(46). 29483–29488. 218 indexed citations

14.

Warren, Robert S., Hui Yuan, Mary Matli, Nancy A. Gillett, & Napoleone Ferrara. (1995). Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis.. Journal of Clinical Investigation. 95(4). 1789–1797. 575 indexed citations breakdown →

15.

Gibbons, R, et al.. (1990). Recombinant IL-4 inhibits IL-6 synthesis by adherent peripheral blood cells in vitro.. PubMed. 9(3). 283–93. 21 indexed citations

16.

Matli, Mary, Gilbert Smolin, & Masao Okumoto. (1987). Use of recombinant interferon in HSV-1 recurrence in the rabbit. Current Eye Research. 6(1). 265–268. 1 indexed citations

17.

Matli, Mary, et al.. (1986). Interferon effects on herpes simplex virus in rabbit and human cell cultures. Current Eye Research. 5(5). 331–335. 2 indexed citations

18.

Mayers, Martin, et al.. (1985). Recombinant human interferon alpha D in HSV-1 recurrence in the rabbit.. PubMed. 26(2). 237–40. 5 indexed citations

19.

Smolin, Gilbert, et al.. (1984). Use of recombinant interferon to prevent recurrent herpesvirus shedding. Current Eye Research. 3(8). 1069–1074. 6 indexed citations

20.

Okumoto, Masao, et al.. (1983). In vitro and in vivo Studies on Cefoperazone. Cornea. 2(1). 35???40–35???40. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact